The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2022

Filed:

Dec. 12, 2018
Applicant:

Neuropace, Inc., Mountain View, CA (US);

Inventors:

Brett Wingeier, San Francisco, CA (US);

Daniel Chao, San Francisco, CA (US);

Benjamin Pless, Atherton, CA (US);

Thomas Tcheng, Pleasant Hill, CA (US);

Assignee:

NeuroPace, Inc., Mountain View, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 5/00 (2006.01); A61N 1/05 (2006.01); A61N 1/30 (2006.01); A61N 5/06 (2006.01); A61B 8/08 (2006.01); A61B 90/10 (2016.01); A61N 1/04 (2006.01); A61N 1/20 (2006.01); A61B 18/02 (2006.01); A61B 18/14 (2006.01); A61B 18/18 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36025 (2013.01); A61B 5/4064 (2013.01); A61B 5/4076 (2013.01); A61B 5/6864 (2013.01); A61B 8/0808 (2013.01); A61B 90/10 (2016.02); A61N 1/0484 (2013.01); A61N 1/0492 (2013.01); A61N 1/0529 (2013.01); A61N 1/0534 (2013.01); A61N 1/0539 (2013.01); A61N 1/205 (2013.01); A61N 1/303 (2013.01); A61N 5/0601 (2013.01); A61B 5/4094 (2013.01); A61B 18/02 (2013.01); A61B 18/14 (2013.01); A61B 2018/1807 (2013.01); A61B 2090/103 (2016.02); A61N 1/0536 (2013.01); A61N 1/36017 (2013.01);
Abstract

Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.


Find Patent Forward Citations

Loading…